Healthcare

New Centers Open At Methodist Hospital

Staff Writer
10/19/2010

A Comprehensive Back and Neck Pain Center has opened at New York Methodist Hospital. The center, which will offer diagnostic and treatment options for disorders of the spine, will emphasize such non-operative options and physical and occupational therapy, medication management, injections and bracing, as well as radiation therapy for metastatic cancer of the spine.
For information: (718) 369-BACK

Stronger Antibiotic Being Developed

Staff Writer
10/19/2010

Dr. Micha Fridman of Tel Aviv University’s department of chemistry is developing what he calls the next generation of antibiotics, which will eb able to combat drug-resistant “superbugs.” The medication, whose research was conducted in collaboration with Sylvie Garneau-Tsodikova of the University of Michigan, is based on turning antibiotics’ bacterial resistance against itself.

Hebrew U. Treatment Effective Against HIV Virus

Staff Writer
10/19/2010

Research at the Hebrew University of Jerusalem may have “groundbreaking implications” for eradicating the HIV virus, according to the school’s research team, the university announced. The treatment, which destroys HIV-infected human cells in laboratory cultures, targets only infected cells without damaging adjacent healthy cells.

Advances In Kidney Disease Research

Staff Writer
10/19/2010

Israeli researchers have isolated a genetic mutation, and genetic patterns in the ancestry of Jews from the Near East, which can be used to combat kidney disease. The work, led by nephrologists Karl Skorecki of the Rambam Medical Center, may lead to a treatment for people who now require dialysis.

New Research From Israel

Bulking up the immune system, molecular imaging, inhibiting breast cancer cells.

Special To The Jewish Week
10/19/2010

T o Ofer Mandelboim, cells infected with viruses and cancer are “enemies” that he must destroy. And a new grant will help him boost his fight against these invaders. “We are surrounded by enemies,” said Mandelboim, a professor of molecular immunology at Hebrew University – Hadassah Medical School’s Lautenberg Center for General and Tumor Immunology. “The question is, why do we live for such a long time? What enables this living is our immune system?”

African AIDS Experts Visit, Learn From Israel

Staff Writer
10/19/2010

(JTA) — A delegation of prominent HIV/AIDS doctors from across East Africa is visiting Israel to expand medical partnerships and benefit from Israel's expertise.

The 10 African medical experts from Botswana, Rwanda, Tanzania, Uganda and Kenya arrived Sunday in Israel for a weeklong visit under the auspices of Project Interchange and the Israeli Consortium on AIDS Medicine in Africa.

Dr. Mark Wainberg, former president of the International AIDS Society and currently director of the McGill University AIDS Center, also joined the seminar.

Drink Milk, Lose More Weight

Staff Writer
10/19/2010

A new weight-loss study conducted by Ben-Gurion University of the Negev (BGU) researchers reveals that dieters who consumed milk or milk products lost more weight on average than those who consumed little to no milk products, according to a release from the university.

When Breast Cancer Meets The Holocaust

For two kinds of ‘survivors,’ filling in the gaps
on family medical history

JTA
10/19/2010

A crucial question left Rifky Atkin speechless. Diagnosed with an aggressive breast cancer, Atkin was exploring treatment options when her surgeon asked, “Is there a history of breast cancer in your family?”

The mother of four from Edison, N.J., stammered, “I don’t know and I’ll never know.”

Her parents survived Auschwitz as teenagers, she explained, but their parents did not. Her four grandparents were killed in the death camp, taking with them all knowledge of the family medical history.

Rifky Atkin, left, with her mother, Ethel, and twin sister.

Stopping Cancer Before It Starts

New book on ‘previvors’ helps women gauge
their risks and sort through prevention options.

Editorial Intern
10/19/2010

Mayde Wiener did not have breast cancer. She did not even have a mutation that would suggest a higher risk of cancer. Yet five years ago, at the age of 45, she made what seems like a counterintuitive — even radical — decision, one that now seems to be backed up by science.

Previvors

Healthcare Oct 2010

Stopping cancer before it starts, when breast cancer meets the Holocaust and new research from Israel.

Staff Writer
10/19/2010
Healthcare Oct 2010
Syndicate content